Ashish Kacholia and Samara Capital backed Sahajanand Medical Technologies files DRHP for IPO

Sahajanand Medical Technologies (SMT) has filed for an IPO with SEBI to raise funds through an offer-for-sale of 27,644,231 equity shares. Prominent shareholders like Samara Capital and Kotak Pre-IPO Opportunities Fund will be offloading shares. A leading player in India’s drug-eluting stent market, SMT boasts a 25% market share. The company’s revenue increased to ₹1,024.

Valuations high, earnings weak — Markets may pause

Despite geopolitical tensions, global equity markets, including India’s Nifty, have shown resilience. While domestic investor participation provides support, a significant breakout requires stronger earnings growth, currently facing tepid levels. India’s robust macros and potential trade deal outcomes could drive future earnings recovery, particularly in the banking sector, though elevated valuations suggest patience is warranted.

IDFC First Bank Q1 results: PAT declines 32% YoY, NII rises by 5.5%

IDFC First Bank’s first quarter of fiscal year 2026 reveals a mixed financial performance. While the profit after tax declined by 32% year-over-year to ₹463 crore, the net interest income experienced a growth of 5.1%, reaching ₹4,933 crore. However, on a quarter-on-quarter basis, the PAT grew significantly by 52.1%.

NephroPlus files DRHP with Sebi, to raise Rs 353 crore via fresh issue

Nephrocare Health Services, known as NephroPlus, plans to raise funds through an IPO. The IPO includes fresh shares and an offer for sale. Funds will be used for new dialysis clinics and debt repayment. The company is a major dialysis services provider in Asia. It has clinics in multiple countries. ICICI Securities and other firms […]

F&O Talk| Nifty extends losing streak for 4th week, bearish signals deepen: Sudeep Shah

The Nifty index is on a four-week losing streak, influenced by underwhelming Q1 earnings and global trade concerns. Nifty Bank outperformed but faces resistance. Bajaj Finance declined post-earnings. IEX is under pressure due to market coupling news. Healthcare and Pharma sectors show promise. Cipla and Apollo Hospital are likely to do well. The market needs […]

Concurrent Gainers: 12 stocks gain for 5 days in a row

Over the five trading sessions ending on July 25, the Sensex declined by 0.36%, or 295 points, finishing at 81,463. The index closed in the red on three of the five days. While the broader market showed signs of weakness during the week, 12 stocks with a market capitalization exceeding Rs 2,500 crore consistently posted […]